CIK 0001894525
- Emerging growth company
Apimeds Pharmaceuticals US, Inc.
Sign in to watch- Ticker
- APUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851099700
- Phone
- +1 848-201-5010
- Business address
- 100 MATAWAN RD, SUITE 325, MATAWAN, NJ, 07747
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13D Stake Beneficial Ownership Report
Page 1 of 1 · 6 filings